Advertisement
Screener

CHEMBIO DIAGNOSTICS, INC. Forms 3, 4 and 5: Stock Options, 2018

CHEMBIO DIAGNOSTICS, INC. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 26 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2018-10-17: Reporting owner Gyorke David; Form 3; Security Options to Purchase Common Stock; Transaction Holding.
  • 2018-10-17: Reporting owner Passas Robert; Form 3; Security Options to Purchase Common Stock; Transaction Holding.
  • 2018-08-13: Reporting owner POLAN MARY LAKE PH D; Form 3; Security Option to Purchase Common Stock; Transaction Holding.
  • 2018-08-13: Reporting owner POLAN MARY LAKE PH D; Form 3; Security Option to Purchase Common Stock; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2018-10-17
holding as of filing
Gyorke David
Officer (See Remarks)
3Options to Purchase Common Stock
Derivative · Direct
Holding$6.30
exercise price
2018-10-17
2018-10-17
holding as of filing
Passas Robert
Officer (See Remarks)
3Options to Purchase Common Stock
Derivative · Direct
Holding$7.15
exercise price
2018-10-17
2018-08-13
holding as of filing
POLAN MARY LAKE PH D
Director
3Option to Purchase Common Stock
Derivative · Direct
Holding$11.45
exercise price
2018-08-13
2018-08-13
holding as of filing
POLAN MARY LAKE PH D
Director
3Option to Purchase Common Stock
Derivative · Direct
Holding$11.45
exercise price
2018-08-13
2018-08-13
holding as of filing
POLAN MARY LAKE PH D
Director
3Option to Purchase Common Stock
Derivative · Direct
Holding$11.45
exercise price
2018-08-13
2018-08-13
holding as of filing
POLAN MARY LAKE PH D
Director
3Option to Purchase Common Stock
Derivative · Direct
Holding$11.45
exercise price
2018-08-13
2018-08-13
holding as of filing
POLAN MARY LAKE PH D
Director
3Option to Purchase Common Stock
Derivative · Direct
Holding$11.45
exercise price
2018-08-13
2018-06-13Esfandiari Javan
Officer (Chief Science/Tech Officer)
4Options to purchase common stock
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−20,000
0 owned after
$5.64
exercise price
2018-06-15
2018-05-16Klugewicz Sharon W
Officer (President, Americas)
4Options to purchase common stock
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−2,500
0 owned after
$4.50
exercise price
2018-05-18
2018-05-16Klugewicz Sharon W
Officer (President, Americas)
4Options to purchase common stock
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−2,500
0 owned after
$4.50
exercise price
2018-05-18
2018-05-16
holding as of filing
Potthoff John Gary
Director
3Option to Purchase Common Stock
Derivative · Direct
Holding$8.15
exercise price
2018-05-16
2018-05-16
holding as of filing
Potthoff John Gary
Director
3Option to Purchase Common Stock
Derivative · Direct
Holding$8.15
exercise price
2018-05-16
2018-05-16
holding as of filing
Potthoff John Gary
Director
3Option to Purchase Common Stock
Derivative · Direct
Holding$8.15
exercise price
2018-05-16
2018-05-16
holding as of filing
Potthoff John Gary
Director
3Option to Purchase Common Stock
Derivative · Direct
Holding$8.15
exercise price
2018-05-16
2018-05-16
holding as of filing
Potthoff John Gary
Director
3Option to Purchase Common Stock
Derivative · Direct
Holding$8.15
exercise price
2018-05-16
2018-02-26Meller Gary
Director
4Options to purchase common stock
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−8,750
0 owned after
$3.48
exercise price
2018-02-27
2018-02-26Meller Gary
Director
4Options to purchase common stock
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−9,375
0 owned after
$3.48
exercise price
2018-02-27
2018-02-26Meller Gary
Director
4Options to purchase common stock
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−9,375
0 owned after
$3.48
exercise price
2018-02-27
2018-02-26Meller Gary
Director
4Options to purchase common stock
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−9,375
0 owned after
$3.48
exercise price
2018-02-27
2018-01-16Esfandiari Javan
Officer (Chief Science/Tech Officer)
4Options to Purchase
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−10,000
0 owned after
$5.44
exercise price
2018-01-18
2018-01-16Esfandiari Javan
Officer (Chief Science/Tech Officer)
4Options to Purchase
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−10,000
0 owned after
$5.44
exercise price
2018-01-18
2018-01-16Esfandiari Javan
Officer (Chief Science/Tech Officer)
4Options to Purchase
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−10,000
0 owned after
$5.44
exercise price
2018-01-18
2018-01-16Esfandiari Javan
Officer (Chief Science/Tech Officer)
4Options to Purchase
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−17,730
0 owned after
$5.64
exercise price
2018-01-18
2018-01-16Esfandiari Javan
Officer (Chief Science/Tech Officer)
4Options to Purchase
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−4,765
0 owned after
$5.56
exercise price
2018-01-18
2018-01-16Esfandiari Javan
Officer (Chief Science/Tech Officer)
4Options to Purchase
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−5,000
0 owned after
$5.25
exercise price
2018-01-18
2018-01-16Esfandiari Javan
Officer (Chief Science/Tech Officer)
4Options to Purchase
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−2,270
0 owned after
$5.64
exercise price
2018-01-18